Marc Giroux, CEO, Kurve Therapeutics - LSI USA `22 Emerging Medtech Summit - Video
Marc Giroux, CEO of Kurve Therapeutics, was a presenter at the LSI USA ‘22 Emerging Medtech Summit, presenting to an audience of active investors and strategic partners. Kurve brings a breakthrough approach to treat CNS disorders like Mild Cognitive Impairment, Alzheimer's, and Parkinson's. Kurve has completed Phases I, II, IIB and is Phase III ready in MCI. Kurve successfully delivers our proprietary medications through the blood brain barrier with a next generation drug delivery technology. Kurve brings revolutionary new treatments for CNS disorders through technology and drugs that modify the disease, creating breakthrough successes in medication effectiveness and quality of life. With demonstrated clinical efficacy, Kurve is changing the landscape of CNS therapies.
Customer comments
No comments were found for Marc Giroux, CEO, Kurve Therapeutics - LSI USA `22 Emerging Medtech Summit - Video. Be the first to comment!